Structural Formula (992e78b1 Bd2c 4e54 8a3f 425e8aea8542 01)
Ondansetron Hydrochloride Solution
Product Images NDC 55154-4453
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 55154-4453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ceb5cebe 9feb 4009 Aa71 5c1fa88104ce 00
This is a package containing five single-use vials of 4mg/2mL Ondansetron Injection. It is to be administered through the intravenous or intramuscular route and is sterile. Each 1 mL contains 2mg of Ondansetron hydrochloride dihydrate, sodium chloride, citric acid monohydrate, and sodium citrate dihydrate. The package comes with a product insert that has dosage and administration information, prescribing information, precautions, and warnings. The unit dose package is not child-resistant and is intended for institutional use only. It should be kept away from the reach of children and protected from light until the time of use. It should be stored at 20° to 25° C. This package is manufactured for Baxter Healthcare Corporation in Deerfield, IL, USA, manufactured by Baxter Pharmaceuticals India Private Ltd in Ahmedabad, India, and distributed by Cerdinal Health in Dublin, OH.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
